New treatment paradigm for hemophilia poses challenges for legacy bioassays
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.14550
Abstract: The one‐stage factor VIII (FVIII) clotting assay measures the extent by which a plasma sample corrects the coagulation time of FVIII‐ deficient plasma in an activated partial thromboplastin time (aPTT)‐ based assay.1 The availability of… read more here.
Keywords: treatment; one stage; fviii; fviii assays ... See more keywords